1. Patients hospitalized with COVID-19 receiving at least one dose of molnupiravir did not show reduced mortality compared to patients ...
1. The use of COVID-19 convalescent plasma did not benefit patients hospitalized with COVID-19, assessed using the World Health Organization ...
1. Compared to patients who received remdesivir for 10 days, those in the 5-day group experienced no significant difference in ...
1. Adults with severe COVID-19 treated with remdesivir had numerically faster time to clinical improvement compared to controls, but the ...
1. In this study, nearly 70% of patients who received remdesivir for compassionate use had an improvement in oxygen-support class ...
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial 1. Adults with severe COVID-19 treated with remdesivir ...
1. In this study, nearly 70% of patients who received remdesivir for compassionate use had an improvement in oxygen-support class ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.